Alejandro Arenas‐Pinto

3.1k citations

67 papers · 2.2k · 2 hit papers · h-index 22

Impact in

Infectious Diseases top 1%
- SARS-CoV-2 and COVID-19 Research
- HIV/AIDS drug development and treatment
- COVID-19 Clinical Research Studies
- HIV/AIDS Research and Interventions
Virology top 2%
- HIV Research and Treatment

Papers in

Infectious Diseases 28
- HIV/AIDS drug development and treatment 15
- HIV/AIDS Research and Interventions 6
- SARS-CoV-2 and COVID-19 Research 4
Virology 13
- HIV Research and Treatment 12

Co-authors: Ian V.D. Weller (5 shared papers)David Dunn (11 shared papers)Nicholas I. Paton (15 shared papers)Ana Milinkovic (9 shared papers)Alison D. Grant (5 shared papers)Wolfgang Stöhr (13 shared papers)SG Edwards (1 shared paper)Alan Winston (12 shared papers)
Journals: Clinical Infectious Diseases (8 papers)AIDS (7 papers)Antiviral Therapy (7 papers)HIV Medicine (5 papers)American Journal of Tropical Medicine and Hygiene (3 papers)
Partner nations: United Kingdom Singapore Denmark

In The Last Decade

Alejandro Arenas‐Pinto

64 papers receiving 2.1k citations

Alejandro Arenas‐Pinto's Hit Papers

align trajectories log scale

SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN) 2021 · 443 citations

What are hit papers?

Paper score: A paper's citations measured against the top-1% bar of its own field and year: the square root of citations ÷ bar, so 1 means right at the bar and 2 means four times its citations. The bar blends the citation counts that enter the top 1% of the paper's subfields in its year (weighted 89.5%), of those subfields over all years (0.5%) and of its year across all fields (10%); a subfield and year with fewer than 400 papers takes its year's bar. Papers from 2026 are not scored yet: in an unfinished year, when a paper appeared matters more than how it is cited.

Hit paper: A paper cited at least 1.5× the top-1% bar of its field and year: a paper score of at least √1.5.

2021 The Lancet
2021 The Lancet

Peers

Countries citing papers authored by Alejandro Arenas‐Pinto

Since Specialization

Citations

This map shows the geographic impact of Alejandro Arenas‐Pinto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alejandro Arenas‐Pinto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alejandro Arenas‐Pinto more than expected).

Fields of papers citing papers by Alejandro Arenas‐Pinto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alejandro Arenas‐Pinto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alejandro Arenas‐Pinto. The network helps show where Alejandro Arenas‐Pinto may publish in the future.

Co-authors

The 25 scholars most cited alongside Alejandro Arenas‐Pinto, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Alejandro Arenas‐Pinto Line = papers co-authored together Alejandro Arenas‐Pinto links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 67 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study The Lancet ·Victoria Jane Hall, Sarah Foulkes, Ayoub Saei, Nick J Andrews, Blanché Oguti, André Charlett, Edgar Wellington, Julia Stowe Hit paper breakdown →	2021	577
2	SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN) The Lancet ·Victoria Jane Hall, Sarah Foulkes, André Charlett, Ana Atti, Edward J M Monk, Ruth Simmons, Edgar Wellington, Michelle Jayne Cole Hit paper breakdown →	2021	443
3	Protease inhibitor monotherapy for long-term management of HIV infection: a randomised, controlled, open-label, non-inferiority trial The Lancet HIV ·Nicholas I. Paton, Wolfgang Stöhr, Alejandro Arenas‐Pinto, Ian G. Williams, Margaret Johnson, Chloe M. Orkin, Fabian Chen, Vincent Lee	2015	71
4	Nucleoside reverse-transcriptase inhibitor cross-resistance and outcomes from second-line antiretroviral therapy in the public health approach: an observational analysis within the randomised, open-label, EARNEST trial The Lancet HIV ·Nicholas I. Paton, Leonard Bagenda, Joep J. van Oosterhout, Silvia Bertagnolio, Ann Sarah Walker, E Agweng, Peter Awio, G Bakeinyaga	2017	71
5	Lactic acidosis in HIV infected patients: a systematic review of published cases Sexually Transmitted Infections ·Alejandro Arenas‐Pinto, Alison D. Grant, SG Edwards, Ian V.D. Weller	2003	70
6	Neurocognitive Function in HIV Infected Patients on Antiretroviral Therapy PLoS ONE ·Alan Winston, Alejandro Arenas‐Pinto, Wolfgang Stöhr, Martin Fisher, Chloe M. Orkin, Kazeem Aderogba, Andrew De Burgh-Thomas, Nigel O’Farrell	2013	56
7	ISOSPORIASIS IN VENEZUELAN ADULTS INFECTED WITH HUMAN IMMUNODEFICIENCY VIRUS: CLINICAL CHARACTERIZATION American Journal of Tropical Medicine and Hygiene ·Gabriela Certad, Alejandro Arenas‐Pinto, Leonor A. Pocaterra, Giuseppe Ferrara, JULIO CASTRO, ANDREINA BELLO, Luz Núñez	2003	50
8	SARS-CoV-2 inhibition using a mucoadhesive, amphiphilic chitosan that may serve as an anti-viral nasal spray Scientific Reports ·Krzysztof Pyrć, Aleksandra Milewska, Emilia Barreto-Durán, Paweł Botwina, Agnieszka Dąbrowska, Malwina Jędrysik, Małgorzata Benedyk, Rui M. Lopes	2021	46
9	Reversible effect on lipids by switching from tenofovir disoproxil fumarate to tenofovir alafenamide and back AIDS ·Ana Milinkovic, F. Berger, Alejandro Arenas‐Pinto, Stefan Mauss	2019	45
10	Nevirapine Increases High-Density Lipoprotein Cholesterol Concentration by Stimulation of Apolipoprotein A-I Production Arteriosclerosis Thrombosis and Vascular Biology ·Remco Franssen, Raaj R. Sankatsing, Elly A. M. Hassink, Barbara A. Hutten, Mariëtte T. Ackermans, Kees Brinkman, René Oesterholt, Alejandro Arenas‐Pinto	2009	38
11	Lopinavir plus nucleoside reverse-transcriptase inhibitors, lopinavir plus raltegravir, or lopinavir monotherapy for second-line treatment of HIV (EARNEST): 144-week follow-up results from a randomised controlled trial The Lancet Infectious Diseases ·James Hakim, JA Thompson, Cissy M Kityo, Anne Hoppé, Andrew Kambugu, Joep J. van Oosterhout, Abbas Lugemwa, Abraham Mosigisi Siika	2017	38
12	CRYPTOSPORIDIOSIS IN HIV-INFECTED VENEZUELAN ADULTS IS STRONGLY ASSOCIATED WITH ACUTE OR CHRONIC DIARRHEA American Journal of Tropical Medicine and Hygiene ·Gabriela Certad, Alejandro Arenas‐Pinto, Leonor A. Pocaterra, Giuseppe Ferrara, JULIO CASTRO, ANDREINA BELLO, Luz Núñez	2005	37
13	Causes and Timing of Mortality and Morbidity Among Late Presenters Starting Antiretroviral Therapy in the REALITY Trial Clinical Infectious Diseases ·Frank A. Post, Alexander J. Szubert, Andrew J. Prendergast, Victoria J. Johnston, Hermione Lyall, Felicity Fitzgerald, Victor Musiime, Godfrey Musoro	2018	36
14	The Risk of Developing Peripheral Neuropathy Induced by Nucleoside Reverse Transcriptase Inhibitors Decreases over Time: Evidence from the Delta Trial Antiviral Therapy ·Alejandro Arenas‐Pinto, Krishnan Bhaskaran, David Dunn, Ian V.D. Weller	2008	35
15	Short- and long-term mortality and causes of death in HIV/tuberculosis patients in Europe European Respiratory Journal ·Daria N. Podlekareva, Alexander M. Panteleev, Daniel J. Grint, Frank A. Post, José Maria Miró, Mathias Bruyand, Hansjakob Furrer, Niels Obel	2013	31
16	Week 48 efficacy and central nervous system analysis of darunavir/ritonavir monotherapy versus darunavir/ritonavir with two nucleoside analogues AIDS ·Andrea Antinori, Amanda Clarke, V Svedhem-Johansson, José Ramón Arribas, Alejandro Arenas‐Pinto, Jan Sven Fehr, Jan Gerstoft, Andrzéj Horban	2015	31
17	Cognitive Function in Young Persons With and Without Perinatal HIV in the AALPHI Cohort in England: Role of Non–HIV-Related Factors Clinical Infectious Diseases ·Ali Judd, Marthe Le Prevost, Diane Melvin, Alejandro Arenas‐Pinto, Francesca Parrott, Alan Winston, Caroline Foster, Kate Sturgeon	2016	31
18	Anxiety and depression symptoms in young people with perinatally acquired HIV and HIV affected young people in England AIDS Care ·Marthe Le Prevost, Alejandro Arenas‐Pinto, Diane Melvin, Francesca Parrott, Caroline Foster, Deborah Ford, Michael Evangeli, Alan Winston	2018	29
19	Peripheral neuropathy in HIV patients in sub-Saharan Africa failing first-line therapy and the response to second-line ART in the EARNEST trial Journal of NeuroVirology ·Alejandro Arenas‐Pinto, JA Thompson, Godfrey Musoro, Hellen Wambongo Musana, Abbas Lugemwa, Andrew Kambugu, Aggrey Mweemba, Dickens Atwongyeire	2015	28
20	Late Presentation With HIV in Africa: Phenotypes, Risk, and Risk Stratification in the REALITY Trial Clinical Infectious Diseases ·Abraham Mosigisi Siika, Leanne McCabe, Mutsa Bwakura‐Dangarembizi, Cissy M Kityo, Jane Mallewa, J Berkley, Kathryn Maitland, Anna Griffiths	2018	27

About Alejandro Arenas‐Pinto

Alejandro Arenas‐Pinto is a scholar working on Infectious Diseases, Virology, Emergency Medicine, Epidemiology and Parasitology, having authored 67 papers that have together received 2.2k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (15 papers), HIV Research and Treatment (12 papers), HIV-related health complications and treatments (12 papers), HIV/AIDS Research and Interventions (6 papers), SARS-CoV-2 and COVID-19 Research (4 papers), Parasitic Infections and Diagnostics (3 papers), Pneumocystis jirovecii pneumonia detection and treatment (2 papers) and HIV, Drug Use, Sexual Risk (2 papers). The work is most often cited by research in Infectious Diseases (1.4k citations), Virology (290 citations), Modeling and Simulation (196 citations), Health (266 citations) and Emergency Medicine (222 citations). Alejandro Arenas‐Pinto has collaborated with scholars based in United Kingdom, Singapore and Denmark. Frequent co-authors include Ian V.D. Weller, David Dunn, Nicholas I. Paton, Ana Milinkovic, Alison D. Grant, Wolfgang Stöhr, SG Edwards, Alan Winston, Giuseppe Ferrara and Gabriela Certad. Their work appears in journals such as Clinical Infectious Diseases, AIDS, Antiviral Therapy, HIV Medicine and American Journal of Tropical Medicine and Hygiene.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Alejandro Arenas‐Pinto

Impact in

Papers in i

In The Last Decade

Alejandro Arenas‐Pinto

Alejandro Arenas‐Pinto's Hit Papers

Peers

Countries citing papers authored by Alejandro Arenas‐Pinto

Fields of papers citing papers by Alejandro Arenas‐Pinto

All Works

About Alejandro Arenas‐Pinto

Explore authors with similar magnitude of impact

Papers in